Contact Us

All Categories

LOXO-195 (Selitrectinib)

Next-generation, selective TRK inhibitor, overcoming the resistance for larotrectinib (LOXO-101) or multikinase inhibitors with anti-TRK activity


Loxoprofen

Non-selective cyclooxygenase inhibitor, as a non-steroidal anti-inflammatory drug (NSAID)


LP-533401 HCl

Novel inhibitor of tryptophan hydroxylase-1 (Tph-1), the initial enzyme in gut-derived serotonin (GDS) biosynthesis.


LP99

Novel BRD7/9 specific inhibitor, binding to BRD9 with a higher potency (Kd=99nM) than to BRD7 (Kd=909nM, ITC), with no off-target selectivity in vitro


LRE1 (RU-0204277)

Novel specific and allosteric inhibitor of soluble adenylyl cyclase (sAC), binding to the bicarbonate activator binding site and inhibiting sAC via a unique allosteric mechanism, preventing sAC-dependent processes in cellular and physiological syst..


LRRK2-IN-1

ATP competitive and selective inhibitor of the Parkinson's disease kinase


LSN2463359

Novel positive allosteric modulator of the mGlu5 receptor


LT175

Novel PPARα/γ ligand with potent insulin sensitizing effects and reduced adipogenic properties


LTI-291

Glucocerebrosidase (Gcase) activator for treatment of Parkinson's disease (PD)


Lu AF21934

Novel, selective positive allosteric modulator of the mGlu4 receptor


Lu AF32615 (TCN-238)

Selective and brain-penetrant positive allosteric modulators (PAMs) of the mGlu4 receptor


LuAA33810

Potent neuropeptide Y (NPY) Y5 receptor antagonist